Heart Attack

AliveCor Announces Dual FDA Clearance of AI Technology That Delivers 35 Cardiac Determinations and First-of-its-Kind Kardia 12L ECG SystemAliveCor Announces Dual FDA Clearance of AI Technology That Delivers 35 Cardiac Determinations and First-of-its-Kind Kardia 12L ECG System

AliveCor Announces Dual FDA Clearance of AI Technology That Delivers 35 Cardiac Determinations and First-of-its-Kind Kardia 12L ECG System

World's First AI to Detect 35 Cardiac Determinations, Including Heart Attack, Using a Reduced Leadset Powered by this AI, the…

1 year ago
Erie County Medical Center Leverages Brook Health’s AI and Remote Care Platform to Transform Hypertension ManagementErie County Medical Center Leverages Brook Health’s AI and Remote Care Platform to Transform Hypertension Management

Erie County Medical Center Leverages Brook Health’s AI and Remote Care Platform to Transform Hypertension Management

Collaboration Doubles Blood Pressure Control for High-Risk Patients in 12 Weeks BUFFALO, N.Y., June 25, 2024 /PRNewswire/ -- Brook Health,…

1 year ago
Single-Cell Functional Profiling Using Nanovial Technology Unveils the Therapeutic Potential of Extracellular VesiclesSingle-Cell Functional Profiling Using Nanovial Technology Unveils the Therapeutic Potential of Extracellular Vesicles

Single-Cell Functional Profiling Using Nanovial Technology Unveils the Therapeutic Potential of Extracellular Vesicles

LOS ANGELES, June 18, 2024 /PRNewswire/ -- Partillion Bioscience Corporation ("Partillion"), a life science tools company, announced a new publication…

1 year ago
Tonix Pharmaceuticals Presented Data Comparing Real-World Treatment of Migraine with Industry Guidelines for Non-Oral Products at the Annual Scientific Meeting of the American Headache Society (AHS)Tonix Pharmaceuticals Presented Data Comparing Real-World Treatment of Migraine with Industry Guidelines for Non-Oral Products at the Annual Scientific Meeting of the American Headache Society (AHS)

Tonix Pharmaceuticals Presented Data Comparing Real-World Treatment of Migraine with Industry Guidelines for Non-Oral Products at the Annual Scientific Meeting of the American Headache Society (AHS)

Gap in non-oral prescriptions relative to AHS guidelines represents an opportunity to increase awareness of Tonix’s two FDA-approved non-oral treatments…

1 year ago
MedsEngine and NI Medical Announce Improved Cardiovascular Outcomes Utilizing NICaS Hemodynamic Measurements with MedsEngine Clinical Decision Support Software for HypertensionMedsEngine and NI Medical Announce Improved Cardiovascular Outcomes Utilizing NICaS Hemodynamic Measurements with MedsEngine Clinical Decision Support Software for Hypertension

MedsEngine and NI Medical Announce Improved Cardiovascular Outcomes Utilizing NICaS Hemodynamic Measurements with MedsEngine Clinical Decision Support Software for Hypertension

DAYTON, Ohio--(BUSINESS WIRE)--MedsEngine and NI Medical are pleased to announce they will be presenting a comprehensive analysis on their management…

1 year ago
Buck Institute and Sens.ai Collaborate to Study Brain AgingBuck Institute and Sens.ai Collaborate to Study Brain Aging

Buck Institute and Sens.ai Collaborate to Study Brain Aging

New Longevity Tech Collaboration Will Research and Develop First-Ever Biological Clock for the Brain WHISTLER, BC, June 6, 2024 /PRNewswire/…

1 year ago
Prevencio Selected for Prestigious MedTech Innovator 2024 Accelerator CohortPrevencio Selected for Prestigious MedTech Innovator 2024 Accelerator Cohort

Prevencio Selected for Prestigious MedTech Innovator 2024 Accelerator Cohort

KIRKLAND, Wash.--(BUSINESS WIRE)--Prevencio, Inc., a leader in AI-powered blood tests for cardiovascular diagnostics, has been selected to join the 2024…

1 year ago
Orchestra BioMed Announces Further Details on In-Person R&D Day in New York Featuring Key Opinion Leaders to Discuss AVIM Therapy Program in Hypertensive Pacemaker Patients on June 11, 2024Orchestra BioMed Announces Further Details on In-Person R&D Day in New York Featuring Key Opinion Leaders to Discuss AVIM Therapy Program in Hypertensive Pacemaker Patients on June 11, 2024

Orchestra BioMed Announces Further Details on In-Person R&D Day in New York Featuring Key Opinion Leaders to Discuss AVIM Therapy Program in Hypertensive Pacemaker Patients on June 11, 2024

NEW HOPE, Pa., June 04, 2024 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”),…

1 year ago